Review of nano technology of Covid 19 vaccines

Mohamed Ashraf
{"title":"Review of nano technology of Covid 19 vaccines","authors":"Mohamed Ashraf","doi":"10.21608/ASAJS.2021.159448","DOIUrl":null,"url":null,"abstract":"103 3 Review of nano technology of Covid 19 vaccines BY Mohamed Ashraf Mohamed, M.A.M., Pharmaceutics department, Egyptian Russian University, ERU Doi: 10.21608/asajs.2021.159448 : ثحبلا ملاتسا 3 / 3 / 2021 : رشنلا لوبق 25 / 3 / 2021 ـــــــــــــــــــــــــــــــــــــــــ ـــــــــــــــــــــ ــــــــــــــــــــــــــــــــــــــــــــــــــــــ Introduction : The global current situation, no return to pre-Covid 19 social pattern unless development of safe preventive vaccines. Fortunately, in the last few months since identity of SARS CoV-2more than two hundred academic laboratories &companies initiated vaccine development, and many are making record time in advancing to clinical trials (Pene, et.al., (2003).","PeriodicalId":209738,"journal":{"name":"المجلة العربیة للعلوم الزراعیة","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"المجلة العربیة للعلوم الزراعیة","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/ASAJS.2021.159448","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

103 3 Review of nano technology of Covid 19 vaccines BY Mohamed Ashraf Mohamed, M.A.M., Pharmaceutics department, Egyptian Russian University, ERU Doi: 10.21608/asajs.2021.159448 : ثحبلا ملاتسا 3 / 3 / 2021 : رشنلا لوبق 25 / 3 / 2021 ـــــــــــــــــــــــــــــــــــــــــ ـــــــــــــــــــــ ــــــــــــــــــــــــــــــــــــــــــــــــــــــ Introduction : The global current situation, no return to pre-Covid 19 social pattern unless development of safe preventive vaccines. Fortunately, in the last few months since identity of SARS CoV-2more than two hundred academic laboratories &companies initiated vaccine development, and many are making record time in advancing to clinical trials (Pene, et.al., (2003).
新型冠状病毒疫苗纳米技术研究进展
103 3对纳米技术的Covid 19穆罕默德·阿什拉夫·默罕默德的疫苗,M.A.M,制药学部门,埃及俄罗斯大学ERU Doi: 10.21608 / asajs.2021.159448:ثحبلاملاتس3 / 3/2021:ارشنلالوبق25 / 3/2021ــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــــ简介:全球现状,没有回到pre-Covid 19社会模式,除非安全预防性疫苗的发展。幸运的是,在SARS - cov -2被发现后的最后几个月里,超过200家学术实验室和公司启动了疫苗开发,许多公司在进入临床试验方面的时间都创下了纪录(Pene等)。,(2003)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信